Literature DB >> 6265244

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

G Jonsson, H Hallman, F Ponzio, S Ross.   

Abstract

The effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on monoamine neurons was studied in mice and rats. In mice DSP4 produced acutely a marked reduction of endogenous noradrenaline (NA), [3H]NA uptake and nerve density of the adrenergic nerves in the iris and atrium. Pronounced accumulations of NA were observed in non-terminal axons, which is a degenerative sign, while no changes were found in the NA cell bodies. A marked recovery of all parameters analysed was found as soon as 1 week after DSP4. In the mouse CNS, however, there was a marked and long-lasting NA reduction, especially in the cerebral and cerebellar cortex and spinal cord, leaving dopamine (DA) and serotonin (5-HT) neurons apparently unaffected. Administration of DSP4 to adult rats produced regional changes in the NA levels of the CNS were similar to those observed in the mouse. There were no indications of DSP4 affecting dopamine and adrenaline neurons in rat CNS, although a minor 5-HT depleting effect was noted. DSP4 treatment resulted in an increase in beta-adrenoceptor binding in vitro to homogenates from the cerebral cortex, using [3H]dihydroalprenolol as radioligand. Treatment of newborn rats with DSP4 caused permanent NA disappearance in the cerebral cortex and spinal cord, whereas marked NA increases were found in the pons-medulla and cerebellum. Administration of DSP4 to pregnant rats (gestation day 15) led to a marked and permanent NA depletion in the cerebral cortex and spinal cord in the offspring. The results support the view that DSP4 can produce an acute and relatively selective degeneration of NA nerve terminals in the rat and mouse. The results furthermore indicate that DSP4 (systemically administered) causes a preferential degeneration of NA nerve terminal projections originating from the locus coeruleus in the CNS. Since DSP4 can pass both the blood-brain and blood-placenta barrier and appears to have potent neurotoxic actions on NA neurons, DSP4 may serve as a useful denervation tool for the analysis of NA transmitter functions, particularly in the CNS of both adult and developing animals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265244     DOI: 10.1016/0014-2999(81)90272-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  94 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

2.  Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y cells.

Authors:  Yan Wang; Phillip R Musich; Moises A Serrano; Yue Zou; Jia Zhang; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2013-08-31       Impact factor: 3.911

3.  Neurotoxin-induced DNA damage is persistent in SH-SY5Y cells and LC neurons.

Authors:  Yan Wang; Phillip R Musich; Kui Cui; Yue Zou; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2015-03-01       Impact factor: 3.911

4.  Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.

Authors:  V Bruto; C Beauchamp; R M Zacharko; H Anisman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.

Authors:  I B Introini; C M Baratti; P Huygens
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Differential sensitivity of pinna reflex and esophageal temperature to clonidine in mice depleted of central noradrenaline by DSP-4.

Authors:  U Lerner; A Larsson
Journal:  Experientia       Date:  1984-09-15

7.  Retarded acquisition of a temporal discrimination following destruction of noradrenergic neurones by systemic treatment with DSP4.

Authors:  M Y Ho; D N Velazquez Martinez; M Lopez Cabrera; S S al-Zahrani; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

8.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

9.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose-, time- and parameter-dependency.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

10.  Increasing CNS noradrenaline reduces EAE severity.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anthony Sharp; Susan McGuire; Elena Galea; Douglas L Feinstein
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.